HopeStage
Back to all studies
Recruitment unclearEUCTR 2017-003288-36

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD)

This historical record does not confirm current site availability.

Historical research recordMultiple countries
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with depression. Other eligibility criteria apply.

Listed locations
Czechia · Denmark and 6 more locations
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Enrollment listed in the registry
216
Sponsor
COMPASS Pathways, Ltd
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom, Czechia, Denmark, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2017-003288-36
Official title
Show the full official title

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD)

Recruitment & locations

Status unknown

Czechia · Denmark · Germany

5 more locations
  • Ireland
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom
Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is COMPASS Pathways, Ltd.

Who can participate?

This study is for people with depression. Other eligibility criteria apply.

Want to explore more studies?

Explore studies